MIRA Pharmaceuticals, Inc. Share Price
MIRAMIRA Pharmaceuticals, Inc. Stock Performance
Open $1.18 | Prev. Close $1.18 | Circuit Range N/A |
Day Range $1.18 - $1.19 | Year Range $0.73 - $2.44 | Volume 1,342 |
Average Traded $1.18 |
MIRA Pharmaceuticals, Inc. Share Price Chart
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
MIRA Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $1.17 | $1.20 | +4.35% |
05-Feb-26 | $1.23 | $1.15 | -4.56% |
04-Feb-26 | $1.18 | $1.21 | +2.12% |
03-Feb-26 | $1.20 | $1.18 | -2.07% |
02-Feb-26 | $1.22 | $1.21 | -3.21% |
30-Jan-26 | $1.27 | $1.25 | +0.40% |
29-Jan-26 | $1.34 | $1.24 | -7.12% |